Logo

Ronen Tamir

Dec 04, 2007
Premium
Rosetta Genomics this week appointed Ronen Tamir as executive vice president of marketing and communication. He has been charged with leading the commercialization of the firm’s miRNA diagnostics products. 
 
Tamir previously served as vice president of investor relations for North America at Novartis. Prior to joining Novartis in 2004, he held several key positions at Serono.
 

Tamir holds a degree in biology from Bar-Ilan University in Israel and an MBA from Warwick Business School in the UK.

Filed under

Microarrays & Multiplexing
microarrays
Breaking News
The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.